Susquehanna International Group’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Susquehanna International Group’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-48,300	Closed	-$161K	–	11307
2019 Q4	$161K	Sell	48,300 -20,700	-30%	-$65.8K	﹤0.01%	8914
2019 Q3	$210K	Buy	+69,000	New	+$194K	﹤0.01%	9008
2019 Q2	–	Sell	-60,500	Closed	-$227K	–	11163
2019 Q1	$227K	Buy	+60,500	New	+$227K	﹤0.01%	7692
2018 Q4	–	Sell	-62,700	Closed	-$359K	–	10457
2018 Q3	$359K	Buy	62,700 +31,900	+104%	+$182K	﹤0.01%	7125
2018 Q2	$154K	Buy	30,800 +18,500	+150%	+$95.2K	﹤0.01%	8823
2018 Q1	$63K	Buy	+12,300	New	+$74K	﹤0.01%	8889
2017 Q2	–	Sell	-182,800	Closed	-$905K	–	10154
2017 Q1	$905K	Buy	+182,800	New	+$1.76M	﹤0.01%	5341

Susquehanna International Group's FOMX Position: Q1 2020 in Review

Susquehanna International Group sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 74,496 shares — an estimated $248K sold.

Susquehanna International Group first reported a position in FOMX in Q2 2016 and held it in 9 quarters. The position peaked at $559K in Q3 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

Susquehanna International Group reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
Susquehanna International Group sold 74,496 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $248K.
Susquehanna International Group first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2016 and held it in 9 quarters.
Susquehanna International Group's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $559K in Q3 2019.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.